MacKinnon Touts College of Pharmacy Successes During Annual Address
On Wednesday, Oct. 18, Dean Neil MacKinnon, PhD, gave his state of the college address to summarize the praise-worthy accomplishments of the James L. Winkle College of Pharmacy during the 2016-2017 academic year.
"It is one of our goals to train everyone to be a leader, to create a caring, compassionate attitude and make transformations at the college by doing things that no one else is doing on the planet, says MacKinnon, who has witnessed the colleges strategic planLead, Care, Transformcome to fruition through a multitude of faculty, student and staff efforts.
These accomplishments included:
- Completing a $34 million renovation to the colleges physical plant, to include a new auditorium, new classrooms and laboratories and new student spaces.
- Receiving $1.3 million in donations from 485 donors in fiscal year 2017, with three new endowments, and growing an engaged alumni base.
- Recognizing the first cohort of students in a recently offered graduate certificate and masters program in pharmacy leadership.
- Establishing two academic programs in China, offering a masters degree in cosmetic science with Chongqing Medical University and a masters degree in drug development with Xiamen University.
- Raising student enrollment in the college from 457 students in 2013 to 505 in 2017.
- Increasing research funding from $8.9 million in 2015-16 to $9.3 million in 2016-2017.
- A 94.4 percent first-time pass rate on the North American Pharmacist Licensure Examination (NAPLEX) exam, compared to state average of 92 percent, and the national average of 90 percent.
- A 96.1 percent first-time pass rate on the Multistate Pharmacy Jurisprudence Examination (MPJE) exam, compared to a state average of 92 percent, and a national average of 85 percent.
- New study abroad opportunities for PharmD students in Chile in 2017and in Scotland and Italy in 2018.
Additionally, MacKinnon highlighted the strength of the practice partner collaborations, which give students the opportunity to learn first-hand what area of pharmacy appeals to them and their passion. He also noted the critical role of advocacy and gave examples of how students are engaged in the shaping of legislation within the profession.
MacKinnon, whose contract was renewed in 2017 for an additional five-year term, is already looking to the future.
"Our goal for next year is to hold ourselves accountable on our new strategic plan to see how we are doing in each area so that we can focus and hone in on areas of improvement, he says.
On Wednesday, Oct. 18, Dean Neil MacKinnon, PhD, gave his state of the college address to summarize the praise-worthy accomplishments of the James L. Winkle College of Pharmacy during the 2016-2017 academic year. One of these accomplishments is completing a $34 million renovation to the college s physical plant, to including a new auditorium, new classrooms and new student spaces, pictured here.
Tags
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.